What You Should Know:
- Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic Ventures.
- AutoIND marks a significant advancement in drug development by automating and accelerating the preparation, writing, and review process for Investigational New Drug (IND) applications.
Automating the IND Process: A Game-Changer for Drug
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Color Health Expands Cancer Screening with SkinIO and Bexa Partnerships
What You Should Know:
- Color Health, a leader in comprehensive cancer care, announced today that it is partnering with SkinIO and Bexa to integrate their innovative solutions for skin and breast cancer screening into its Virtual Cancer Clinic.
- The collaboration aims to significantly increase cancer screening and detection rates, making early diagnosis more accessible for employers and individuals.
Bringing Cutting-Edge Screening to the Workplace and Beyond
SkinIO: This
Read More
PathAI Unveils New AI-Powered Pathology Tools for Cancer Research
What You Should Know:
- PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights.
- The product pairing provides unprecedented single-cell and spatial resolution of
Read More
LunaJoy, Ollie Hinkle Partner on Holistic Mental Health Services for Heart Patients
What You Should Know:
- The Ollie Hinkle Heart Foundation (OHHF), a leading non-profit organization dedicated to supporting individuals with childhood-onset heart conditions and their families, today announced a national partnership with LunaJoy Health, a women’s mental health company supporting clinical operations and patient risk
Read More
Virtual Therapeutics Acquires Akili: Stock to Go Private After Merger
What You Should Know:
- Virtual Therapeutics, a leader in using engaging games for mental health treatment, announced today it will acquire Akili, Inc. (Nasdaq: AKLI), a prominent digital therapeutics company. This merger creates a diversified powerhouse in the digital health industry.
- Once the acquisition is complete, Akili's common stock will be delisted from all public stock exchanges. The combined entity's focus on mental health and broader digital therapeutics solutions
Read More
Medable Partners with Masimo to Bring Wearable Devices to Clinical Research, Capturing Better Data
What You Should Know:
- Medable Inc., a leader in modern clinical trial technology, has announced a groundbreaking partnership with Masimo (NASDAQ: MASI) to integrate medical-grade wearable devices into clinical research. This collaboration aims to streamline patient participation and enhance data collection for clinical trials.
- By offering a patient-centric approach and fostering richer data collection, this collaboration holds promise for faster drug development, improved patient
Read More
New AI Test Aims to Improve Breast Cancer Recurrence Prediction: COTA, PreciseDx, and Baptist Health South Florida Collaborate
What You Should Know:
- A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for faster, more accurate, and more affordable risk prediction compared to current methods.
- By utilizing AI technology, PreciseBreast™ has the potential to offer patients a faster, more accurate, and more affordable way to assess their risk of
Read More
Pager Health and League Partner to Address Maternal Health Crisis
What You Should Know:
- Pager Health and League, leading forces in digital healthcare, have joined forces to tackle the critical issue of maternal health in the United States.
- The strategic collaboration aims to deliver a truly personalized and effective maternity care experience, potentially improving outcomes for millions of mothers-to-be.
The U.S. Maternal Health Crisis in Numbers
The United States faces a stark reality when it comes to maternal health. The maternal
Read More
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
What You Should Know:
- Tandem Diabetes Care announced today that its Tandem Mobi insulin pump is fully compatible with Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring (CGM) systems.
- Tandem is now the only company offering two insulin pump options integrated with both Dexcom G6 and Dexcom G7 CGM systems. This choice empowers people with diabetes to select the best solution for their individual needs and preferences.
Tandem Mobi: A Compact and Effective
Read More
Tandem Mobi Integrates with Dexcom G7 CGM, Expanding Choice for Diabetes Management
What You Should Know:
- Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) systems.
- Overall, the Tandem Mobi and Dexcom G7 combination empowers people with diabetes with a discreet, convenient, and technologically advanced solution for managing their condition.
Tandem Mobi: Small Pump, Big Choice for Diabetes
Read More
